A Phase 1 study of AZD1705 in dyslipidemia

Not Yet Recruiting Phase 1 NCT06216353

Study Description

A clinical study to evaluate the safety, tolerability, and effects of an investigational drug called AZD1705 in people with high cholesterol or other lipid disorders

Study Details

Registry ID:
NCT06216353
Conditions:
Cardiovascular
Phase:
Phase 1
Target Enrollment:
112 participants
Start Date:
Age Range:
18–65 years
Healthy Volunteers:
No

Study Locations (2 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →